Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALIA: Nerve Blocks + LIA vs LIA Alone in Knee Replacement
NCT07350252Phase 4Recruiting
- Sponsor
- Region Skåne
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine, clonidine in osteoarthritis (OA), sponsored by Region Skåne. Started Mar 2026; status: recruiting.
02
Drugs
ropivacaineclonidine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07350252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07350252.